Detalhe da pesquisa
1.
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study.
Br J Haematol
; 204(4): 1293-1299, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263627
2.
Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias.
Eur J Haematol
; 112(4): 538-546, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38044594
3.
Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma.
Eur J Haematol
; 112(6): 975-983, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382632
4.
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
Cancer
; 129(23): 3746-3760, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622738
5.
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
Br J Haematol
; 200(5): 587-594, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495317
6.
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
Eur J Haematol
; 110(6): 626-632, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36752328
7.
Palliative care utilization, transfusion burden, and end-of-life care for patients with multiple myeloma.
Eur J Haematol
; 109(5): 559-565, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054450
8.
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
Eur J Haematol
; 109(5): 458-464, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810359
9.
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
Cancer
; 127(22): 4198-4212, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314018
10.
Hospitalization at the end of life in patients with multiple myeloma.
BMC Cancer
; 21(1): 339, 2021 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789626
11.
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
BMC Cancer
; 21(1): 730, 2021 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172037
12.
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM).
Eur J Haematol
; 107(6): 602-608, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378251
13.
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic review.
Am J Hematol
; 96(6): 690-697, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735453
14.
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lancet Oncol
; 21(2): 207-221, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859245
15.
Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings.
Biol Blood Marrow Transplant
; 26(4): 805-813, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31917269
16.
Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta-analysis.
Eur J Haematol
; 104(5): 420-426, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880853
17.
Inpatient mortality of patients with multiple myeloma and renal impairment undergoing autologous stem cell transplantation.
Eur J Haematol
; 105(5): 571-577, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32662224
18.
Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
J Oncol Pharm Pract
; 26(5): 1128-1133, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31795821
19.
Multiple myeloma triplet therapies: baseline characteristics and control groups.
Lancet
; 397(10285): 1620-1621, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933200
20.
Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature.
J Oncol Pharm Pract
; 22(3): 537-42, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712627